XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

AIDS Channel
subscribe to AIDS newsletter

Latest Research : Infectious Diseases : AIDS

   DISCUSS   |   EMAIL   |   PRINT
Lemons could fight the spread of HIV
Sep 19, 2005, 13:04, Reviewed by: Dr.

Parts of Southeast Asia have traditionally used lemon or lime juice as a contraceptive, the acidity of the juice immobilising sperm in less than 30 seconds. Professor Short's team has tested various solutions of the juice on HIV in culture and found that a 20% solution destroyed 90 per cent of the virus within just two minutes.

 
The 2005 Doubleday Lecture at The University of Manchester, entitled "New ways of preventing HIV infection in developing countries," will be given by Professor Roger Short of the Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne on 21 September.

Professor Short spent a year working as a consultant to the World Health Organisations Global Programme on AIDS, where he helped design strategies to integrate HIV prevention with family planning programmes. His current research looks at the way male circumcision protects against HIV infection, as well as new ways of preventing the sexual transmission of HIV in men and women.

The HIV pandemic becomes more serious each day, especially in the developing world, and globally there are 5 million new infections and 3 million deaths a year. Sub-Saharan Africa remains the epicentre of the condition, and the best hope for containing it is to find ways of preventing its spread in young people there - especially women who are becoming infected at a much higher rate than men.

Professor Short will discuss five new approaches including his LemonAIDS project, which has found that the juice of the lemon can kill HIV in a test tube and prompted hopes that an anti-HIV vaginal gel could be developed. With social circumstances often forcing young women in Africa to have sex with older, infected men and making it difficult for them to insist on condom use, scientists have long searched for a readily available, cheap and safe microbicide to kill HIV in the vagina before it has a chance to infect them.

Parts of Southeast Asia have traditionally used lemon or lime juice as a contraceptive, the acidity of the juice immobilising sperm in less than 30 seconds. Professor Short's team has tested various solutions of the juice on HIV in culture and found that a 20% solution destroyed 90 per cent of the virus within just two minutes.

Other sexually transmitted diseases such as syphilis, gonorrhea and chlamydia are also known to be killed by certain levels of acidity, meaning lemon or lime juice could also protect women against these infections. Since around only 3 millilitres of juice (a teaspoonful) is needed per act of intercourse, one lemon goes a long way - and the juice doesn't damage latex condoms.

Laboratory research in Melbourne is almost complete, and human trials are soon to get underway in Thailand. By the time of the next World AIDS Conference in 2006 the team hopes to know whether lemons and limes will prove to be both nature's contraceptive and microbicide, and Professor Short is clearly hopeful, saying, "We've been looking for the microbicidal Cadillac, when all along we've been overlooking the humble push bike."
 

- The Doubleday lecture will take place at 5.30 pm on Wednesday 21 September at The University of Manchester, Oxford Road.
 

www.manchester.ac.uk

 
Subscribe to AIDS Newsletter
E-mail Address:

 

The University of Manchester (www.manchester.ac.uk) was formed by the merger of The Victoria University of Manchester and UMIST in October 2004, and with over 36 000 students is the largest higher education institution in the country. Its Faculty of Medical & Human Sciences (www.mhs.manchester.ac.uk) is one of the largest in Europe, with a research income of over �37 million.

The Doubleday lecture , now in its fourth year, is funded by the Doubleday Fund founded in memory of Dr. Edwin Doubleday, a student at The University of Manchester who died in an accident on the London underground at around the time he completed his medical degree. It promotes interest in non-clinical aspects of patient care in medical training and supports an annual award, the award-holder being asked to deliver a lecture on the subject of his or her choice.



The three previous recipients of the Doubleday Award are Rabbi Julia Neuberger, Director of the King's Fund in London, Sir Kenneth Calman, a former UK Chief Medical Officer, and Professor Arthur Kleinman of the Department of Anthropology at Harvard University, USA.


Related AIDS News

Keeping A3G in action represents a new way to attack HIV
Fighting HIV With HIV Virus Itself
HIV exploits competition among T-cells
Harmless GB Virus type C (GBV-C) protects against HIV infection
Study defines effective microbicide design for HIV/AIDS prevention
HIV depends on human p75, study shows
Simplified treatment of HIV infection shows promise
Clinical trial evaluates first-line approaches for treating HIV
T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
B cells with special protein direct HIV to T cells


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us